Cargando…

Overcoming barriers: Modelling the effect of potential future changes of organized breast cancer screening in Italy

OBJECTIVES: Organized breast cancer screening may not achieve its full potential due to organizational and cultural barriers. In Italy, two identified barriers were low attendance in Southern Italy and, in Italy as a whole, underscreening and overscreening in parts of the eligible population. The ob...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zielonke, Nadine, Senore, Carlo, Ponti, Antonio, Csanadi, Marcell, de Koning, Harry J, Heijnsdijk, Eveline A M, van Ravesteyn, Nicolien T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10399099/ https://www.ncbi.nlm.nih.gov/pubmed/36762395 http://dx.doi.org/10.1177/09691413231153568

Ejemplares similares

Extending Age Ranges in Breast Cancer Screening in Four European Countries: Model Estimations of Harm-to-Benefit Ratios
por: Zielonke, Nadine, et al.
Publicado: (2021)

The EU-TOPIA evaluation tool: An online modelling-based tool for informing breast, cervical, and colorectal cancer screening decisions in Europe
por: Gini, Andrea, et al.
Publicado: (2021)

All‐cause mortality versus cancer‐specific mortality as outcome in cancer screening trials: A review and modeling study
por: Heijnsdijk, Eveline A. M., et al.
Publicado: (2019)

The potential of breast cancer screening in Europe
por: Zielonke, Nadine, et al.
Publicado: (2020)

Interpreting Overdiagnosis Estimates in Population-based Mammography Screening
por: de Gelder, Rianne, et al.
Publicado: (2011)

Finding the optimal mammography screening strategy: A cost‐effectiveness analysis of 920 modelled strategies
por: Kregting, Lindy M., et al.
Publicado: (2022)

Reply to: Comments on “Finding the optimal mammography screening strategy: A cost‐effectiveness analysis of 920 modeled strategies”
por: Kregting, Lindy M., et al.
Publicado: (2022)

Development and Validation of Three Regional Microsimulation Models for Predicting Colorectal Cancer Screening Benefits in Europe
por: Gini, Andrea, et al.
Publicado: (2021)

Collaborative modeling of the impact of obesity on race-specific breast cancer incidence and mortality
por: Chang, Yaojen, et al.
Publicado: (2012)

Detection and interval cancer rates during the transition from screen-film to digital mammography in population-based screening
por: Sankatsing, Valérie D. V., et al.
Publicado: (2018)

Socio-economic inequality of utilization of cancer testing in Europe: A cross-sectional study
por: Bozhar, H., et al.
Publicado: (2022)

Prediction of higher mortality reduction for the UK Breast Screening Frequency Trial: a model-based approach on screening intervals
por: van Ravesteyn, N T, et al.
Publicado: (2011)

Cost‐effectiveness of multiparametric magnetic resonance imaging and MRI‐guided biopsy in a population‐based prostate cancer screening setting using a micro‐simulation model
por: Getaneh, Abraham M., et al.
Publicado: (2021)

Cost-Effectiveness of Magnetic Resonance Imaging Screening for Women With Extremely Dense Breast Tissue
por: Geuzinge, H Amarens, et al.
Publicado: (2021)

Which Strategies Reduce Breast Cancer Mortality Most?: Collaborative Modeling of Optimal Screening, Treatment, and Obesity Prevention
por: Mandelblatt, Jeanne, et al.
Publicado: (2013)

Effects of cancer screening restart strategies after COVID-19 disruption
por: Kregting, Lindy M., et al.
Publicado: (2021)

Correction: Effects of cancer screening restart strategies after COVID-19 disruption
por: Kregting, Lindy M., et al.
Publicado: (2021)

Assessment of harms, benefits, and cost‐effectiveness of prostate cancer screening: A micro‐simulation study of 230 scenarios
por: Getaneh, Abraham M., et al.
Publicado: (2020)

Screening for cancers with a good prognosis: The case of testicular germ cell cancer
por: Heijnsdijk, Eveline A. M., et al.
Publicado: (2021)

The comparative effectiveness of mpMRI and MRI-guided biopsy vs regular biopsy in a population-based PSA testing: a modeling study
por: Getaneh, Abraham M., et al.
Publicado: (2021)

Prostate-Specific Antigen Screening in the United States vs in the European Randomized Study of Screening for Prostate Cancer–Rotterdam
por: Wever, Elisabeth M., et al.
Publicado: (2010)

The Early Detection of Breast Cancer Using Liquid Biopsies: Model Estimates of the Benefits, Harms, and Costs
por: van der Poort, Esmée K. J., et al.
Publicado: (2022)

Experiences, expectations and preferences regarding MRI and mammography as breast cancer screening tools in women at familial risk
por: Geuzinge, H. Amarens, et al.
Publicado: (2021)

Overcoming Barriers to the Effective Management of Severe Asthma in Italy
por: Paggiaro, Pierluigi, et al.
Publicado: (2021)

Effects of lower screening activity during the COVID-19 pandemic on breast cancer patient pathways: Evidence from the age cut-off of organized screening
por: Elek, Péter, et al.
Publicado: (2022)

Facilitators and barriers to screening for child abuse in the emergency department
por: Louwers, Eveline CFM, et al.
Publicado: (2012)

Evaluation of health benefits and harms of the breast cancer screening programme in the Basque Country using discrete event simulation
por: Arrospide, Arantzazu, et al.
Publicado: (2015)

Personalizing Breast Cancer Screening Based on Polygenic Risk and Family History
por: van den Broek, Jeroen J, et al.
Publicado: (2020)

Analysis of Pharmaceutical Industry Payments to UK Health Care Organizations in 2015
por: Ozieranski, Piotr, et al.
Publicado: (2019)

Economic evaluation of the breast cancer screening programme in the Basque Country: retrospective cost-effectiveness and budget impact analysis
por: Arrospide, Arantzazu, et al.
Publicado: (2016)

Colorectal Cancer Screening
por: Quintero, Enrique, et al.
Publicado: (2012)

The cost-effectiveness of different visual acuity screening strategies in three European countries: A microsimulation study
por: Heijnsdijk, Eveline A.M., et al.
Publicado: (2022)

Cost‐effectiveness of surveillance schedules in older adults with non‐muscle‐invasive bladder cancer
por: Heijnsdijk, Eveline A.M., et al.
Publicado: (2018)

The community pharmacy model for colorectal cancer screening: policy insights from Italy
por: Deandrea, S, et al.
Publicado: (2022)

Overcoming Barriers to Walk With Ease Implementation in Community Organizations
por: Vilen, Leigha H., et al.
Publicado: (2021)

To be screened or not to be screened? Modeling the consequences of PSA screening for the individual
por: Wever, E M, et al.
Publicado: (2012)

Progress and Challenges in Colorectal Cancer Screening
por: Quintero, Enrique, et al.
Publicado: (2012)

Development of a breast cancer screening protocol to use automated breast ultrasound in a local setting
por: Tittmann, Judit, et al.
Publicado: (2023)

Using Collaborative Simulation Modeling to Develop a Web-Based Tool to Support Policy-Level Decision Making About Breast Cancer Screening Initiation Age
por: Burnside, Elizabeth S., et al.
Publicado: (2017)

Trade-Offs Between Harms and Benefits of Different Breast Cancer Screening Intervals Among Low-Risk Women
por: van Ravesteyn, Nicolien T, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q3pi0fakqh7l4skimdcmalppkp